Recent advances recent R Re Rec Rece BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
liver diseases liver l li liv live BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 2 0 0 0 0 1
Kazuto Tajiri, kazuto K Ka Kaz Kazu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 10 0 0 0 0 1
Kazuto Tajiri, kazuto K Ka Kaz Kazu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,, 2 10 0 0 0 0 1
University Hospital, university U Un Uni Univ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-, 3 8 0 0 0 0 1
Yukihiro Shimizu, yukihiro Y Yu Yuk Yuki BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,, 2 10 0 0 0 0 1
Hospital, Toyama hospital, H Ho Hos Hosp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-, 3 5 0 0 0 0 1
Author contributions: author A Au Aut Auth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 :, 2 10 0 0 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 4 0 0 0 0 1
Conflict-of-interest statement: conflict-of-interest C Co Con Conf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 --: 3 10 0 0 0 0 1
no conflict no n no no no BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 7 0 0 0 0 1
Open-Access: This open-access: O Op Ope Open BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 -:- 3 9 0 0 0 0 1
selected by selected s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -- 2 10 0 0 0 0 1
reviewers. It reviewers. r re rev revi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
Commons Attribution commons C Co Com Comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 1 (-.), 5 8 0 0 0 0 1
which permits which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,,, 3 9 0 0 0 0 1
work non-commercially, work w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -, 2 9 0 0 0 0 1
different terms, different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 9 0 0 0 0 1
the use the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -.:://./ 8 8 0 0 0 0 1
licenses/by-nc/4.0/ licenses/by-nc/4.0/ licenses/by-nc/4.0/ l li lic lice BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 /-/./ 5 2 0 0 0 0 1
Manuscript source: manuscript M Ma Man Manu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 : 1 10 0 0 0 0 1
Correspondence to: correspondence C Co Cor Corr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 :,,, 4 9 0 0 0 0 1
Gastroenterology, Toyama gastroenterology, G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 ,,, 3 10 0 0 0 0 1
Toyama 939-1724, toyama T To Toy Toya BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 -,..-.. 7 8 0 0 0 0 1
Telephone: +81-76-4347301 telephone: T Te Tel Tele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 :-- 3 4 0 0 0 0 1
Fax: +81-76-4345027 fax: F Fa Fax Fax: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 :-- 3 3 0 0 0 0 1
Received: January received: R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 7 0 0 0 0 1
Peer-review started: peer-review P Pe Pee Peer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 -:, 3 10 0 0 0 0 1
First decision: first F Fi Fir Firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 7 0 0 0 0 1
Revised: March revised: R Re Rev Revi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 6 0 0 0 0 1
Accepted: May accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 5 0 0 0 0 1
Article in article A Ar Art Arti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 7 0 0 0 0 1
Published online: published P Pu Pub Publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :, 2 8 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
Pruritus is pruritus P Pr Pru Prur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 8 0 0 0 0 1
liver diseases, liver l li liv live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 10 0 0 0 0 1
as primary as a as as as BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 8 0 0 0 0 1
patient quality patient p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
to consideration to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 0 0 0 0 1
implicated in implicated i im imp impl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 0 0 0 0 1
peripheral and peripheral p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 8 0 0 0 0 1
the development the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 0 0 0 0 1
evidence for evidence e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 0 0 0 0 1
is currently is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 9 0 0 0 0 1
investigations. investigations. investigations. i in inv inve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 2 0 0 0 0 1
Key words: key K Ke Key Key BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 6 :;;; 4 10 0 0 0 0 1
receptor antagonist receptor r re rec rece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 3 0 0 0 0 1
© The © © © © © BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 7 (). 3 10 0 0 0 0 1
Group Inc. group G Gr Gro Grou BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 .. 2 5 0 0 0 0 1
Core tip: core C Co Cor Core BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 : 1 9 0 0 0 0 1
of life of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
with cholestatic with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 8 0 0 0 0 1
mechanisms have mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 7 0 0 0 0 1
therapeutic options therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 8 0 0 0 0 1
needed for needed n ne nee need BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 8 0 0 0 0 1
in their in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 7 . 1 3 0 0 0 0 1
Tajiri K, tajiri T Ta Taj Taji BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 ,. 2 9 0 0 0 0 1
pruritus in pruritus p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 .; 2 10 0 0 0 0 1
23(19): 3418-3426 23(19): 2 23 23( 23(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 ():-::://.. 11 9 0 0 0 0 1
com/1007-9327/full/v23/i19/3418.htm DOI: com/1007-9327/full/v23/i19/3418.htm c co com com/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 8 /-////.:://.. 13 8 0 0 0 0 1
org/10.3748/wjg.v23.i19.3418 org/10.3748/wjg.v23.i19.3418 org/10.3748/wjg.v23.i19.3418 o or org org/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 /./... 6 4 0 0 0 0 1
INTRODUCTION INTRODUCTION introduction I IN INT INTR BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 10 0 0 0 0 1
Pruritus is pruritus P Pr Pru Prur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 no 0 9 0 0 0 0 1
tients with tients t ti tie tien BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 , 1 10 0 0 0 0 1
with cholestatic with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 10 0 0 0 0 1
cholangitis (PBC) cholangitis c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 () 2 9 0 0 0 0 1
(PSC) (PSC) (psc) ( (P (PS (PSC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 () 2 1 0 0 0 0 1
[1­3] . [1­3] [ [1 [1­ [1­3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 []. 3 8 0 0 0 0 1
characterized by characterized c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 9 0 0 0 0 1
intensity during intensity i in int inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 8 0 0 0 0 1
[4] [4] [4] [ [4 [4] [4] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 [] 2 10 0 0 0 0 1
. Chronic . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 . 1 10 0 0 0 0 1
REVIEW REVIEW review R RE REV REVI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 0 0 0 1
3418 3418 3418 3 34 341 3418 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 10 no 0 1 0 0 0 0 0
May 21, may M Ma May May BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 0 10 , 1 10 0 0 0 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 .. 2 5 0 0 0 0 0
Submit a submit S Su Sub Subm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 :://.. 6 10 0 0 0 0 1
DOI: 10.3748/wjg.v23.i19.3418 doi: D DO DOI DOI: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 :./... 6 10 0 0 0 0 1
World J world W Wo Wor Worl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 ;():- 5 10 0 0 0 0 1
ISSN 1007-9327 issn I IS ISS ISSN BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 -()-() 6 10 0 0 0 0 1
pruritus generally pruritus p pr pru prur BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
at night at a at at at BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 1 0 1 0 0 1
[4,5] [4,5] [4,5] [ [4 [4, [4,5 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 [,] 3 10 0 1 0 0 1
. Women . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 . 1 7 0 1 0 0 1
worsening of worsening w wo wor wors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 10 0 1 0 0 1
hormone replacement hormone h ho hor horm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 5 0 1 0 0 1
[4­6] [4­6] [4­6] [ [4 [4­ [4­6 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 [] 2 10 0 0 0 0 1
. Although . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 . 1 3 0 0 0 0 1
may not may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 0 0 no 0 8 0 0 0 0 1
outcome of outcome o ou out outc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
showed that showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
quality of quality q qu qua qual BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
[7] [7] [7] [ [7 [7] [7] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 . 1 0 0 0 0 0 1
Pruritus may pruritus P Pr Pru Prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
even in even e ev eve even BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 6 0 0 0 0 1
[8,9] [8,9] [8,9] [ [8 [8, [8,9 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 [,] 3 10 0 0 0 0 1
. Recently, . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 1 ., 2 3 0 0 0 0 1
mechanisms underlying mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 10 0 0 0 0 1
advances have advances a ad adv adva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
recent advances recent r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
chronic liver chronic c ch chr chro BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 4 0 0 0 0 1
MECHANISMS OF mechanisms M ME MEC MECH BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 0 0 0 0 1
DISEASES DISEASES diseases D DI DIS DISE BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 0 0 0 0 1
Several lines several S Se Sev Seve BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
by which by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
First, accumulated first, F Fi Fir Firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 9 0 0 0 0 1
pruritogens pruritogens pruritogens p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 2 0 0 0 0 1
[10] . [10] [ [1 [10 [10] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 []. 3 7 0 0 0 0 1
induce degranulation induce i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 9 0 0 0 0 1
may contribute may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 0 1 . 1 9 0 0 0 0 1
However the however H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 8 0 0 0 0 1
pruritus has pruritus p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 5 0 0 0 0 1
[11] , [11] [ [1 [11 [11] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 [], 3 3 0 0 0 0 1
metabolites of metabolites m me met meta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
[12] [12] [12] [ [1 [12 [12] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 . 1 0 0 0 0 0 1
Second, endogenous second, S Se Sec Seco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 , 1 10 0 0 0 0 1
increased in increased i in inc incr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 6 0 0 0 0 1
[12,13] [12,13] [12,13] [ [1 [12 [12, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 [,] 3 10 0 0 0 0 1
. Activation . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 . 1 2 0 0 0 0 1
μ­opioid receptors μ­opioid μ μ­ μ­o μ­op BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 no 0 9 0 0 0 0 1
pain signaling, pain p pa pai pain BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 , 1 9 0 0 0 0 1
showing antipruritic showing s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 10 0 0 0 0 1
cholestasis cholestasis cholestasis c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 no 0 2 0 0 0 0 1
[14,15] . [14,15] [ [1 [14 [14, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 [,]. 4 7 0 0 0 0 1
those increased those t th tho thos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 9 0 0 0 0 1
unclear unclear unclear u un unc uncl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 1 0 0 0 0 1
[12,13] [12,13] [12,13] [ [1 [12 [12, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 [,] 3 10 0 0 0 0 1
. Thus, . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 ., 2 7 0 0 0 0 1
explain the explain e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 ., 2 9 0 0 0 0 1
conditions that conditions c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 10 0 0 0 0 1
in cirrhotic in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 3 . 1 9 0 0 0 0 1
conditions and conditions c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 9 0 0 0 0 1
of diuretics of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 5 0 0 0 0 1
[16] [16] [16] [ [1 [16 [16] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 [] 2 10 0 0 0 0 1
, complicating , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 , 1 3 0 0 0 0 1
mechanism by mechanism m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 no 0 10 0 0 0 0 1
patients. patients. patients. p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 . 1 1 0 0 0 0 1
MECHANISM OF mechanism M ME MEC MECH BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
PERIPHERY PERIPHERY periphery P PE PER PERI BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
Research in research R Re Res Rese BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
of pruritus of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (). 3 9 0 0 0 0 1
first involves first f fi fir firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 9 0 0 0 0 1
slow­conducting C­fibers slow­conducting s sl slo slow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
stimuli, which stimuli, s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 10 0 0 0 0 1
pain transmission pain p pa pai pain BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 3 0 0 0 0 1
[17,18] [17,18] [17,18] [ [1 [17 [17, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 [,] 3 10 0 0 0 0 1
. Mechanical . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 4 . 1 5 0 0 0 0 1
and touch and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 0 0 0 0 1
conducting fibers conducting c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
inhibit itch­transmission inhibit i in inh inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 4 0 0 0 0 1
[19­21] [19­21] [19­21] [ [1 [19 [19­ BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 [] 2 10 0 0 0 0 1
, thus , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 4 , 1 6 0 0 0 0 1
why itching why w wh why why BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
[22] [22] [22] [ [2 [22 [22] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 [] 2 10 0 0 0 0 1
. Scratching . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 . 1 2 0 0 0 0 1
damages the damages d da dam dama BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 10 0 0 0 0 1
substance P substance s su sub subs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 10 0 1 0 0 1
increasing pruritus increasing i in inc incr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 3 0 1 0 0 1
[23] [23] [23] [ [2 [23 [23] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 [] 2 10 0 1 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 . 1 0 0 1 0 0 1
Several pruritogens several S Se Sev Seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 1 0 0 1
to itch to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 10 0 1 0 0 1
the histamine the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 1 0 0 1
the main the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
[24] . [24] [ [2 [24 [24] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 []. 3 2 0 1 0 0 1
receptor interacts receptor r re rec rece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 () 2 9 0 1 0 0 1
[25] [25] [25] [ [2 [25 [25] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 [] 2 10 0 0 0 0 1
and transient and a an and and BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 () 2 9 0 0 0 0 1
receptor subfamily receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (), 3 9 0 0 0 0 1
a nociceptive a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 5 no 0 5 0 0 0 0 1
[26] . [26] [ [2 [26 [26] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 []. 3 5 0 0 0 0 1
receptors (PAR) receptors r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 () 2 10 0 0 0 0 1
in itch in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 no 0 3 0 0 0 0 1
[27] [27] [27] [ [2 [27 [27] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 [] 2 10 0 0 0 0 1
, and , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 , 1 10 0 0 0 0 1
TRPV1, thereby trpv1, T TR TRP TRPV BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 , 1 10 0 0 0 0 1
[28,29] [28,29] [28,29] [ [2 [28 [28, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 [,] 3 10 0 0 0 0 1
. Serotonin . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 . 1 2 0 0 0 0 1
is another is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,,, 3 10 0 0 0 0 1
acts on acts a ac act acts BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 () 2 8 0 0 0 0 1
[26] , [26] [ [2 [26 [26] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 [], 3 1 0 0 0 0 1
such as such s su suc such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 10 0 0 0 0 1
in serotonin­mediated in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 6 no 0 5 0 0 0 0 1
[30] [30] [30] [ [3 [30 [30] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 [] 2 10 0 0 0 0 1
. The . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 . 1 4 0 0 0 0 1
(MrgA3), a (mrga3), ( (M (Mr (Mrg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 (),, 4 10 0 0 0 0 1
signaling signaling signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 2 0 0 0 0 1
[31,32] by [31,32] [ [3 [31 [31, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 [,] 3 6 0 0 0 0 1
[32] [32] [32] [ [3 [32 [32] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 [] 2 10 0 0 0 0 1
. Thus, . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 ., 2 2 0 0 0 0 1
mechanisms underlying mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 9 0 0 0 0 1
Other pruritogens other O Ot Oth Othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 10 0 0 0 0 1
For example, for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 , 1 9 0 0 0 0 1
only by only o on onl only BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 8 0 0 0 0 1
[33] [33] [33] [ [3 [33 [33] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 . 1 0 0 0 0 0 1
Cytokines produced cytokines C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
in itch in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 7 no 0 1 0 0 0 0 1
[22] [22] [22] [ [2 [22 [22] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 [] 2 10 0 0 0 0 1
. Keratinocytes . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 .() 3 8 0 0 0 0 1
with itching. with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 10 0 0 0 0 1
associated molecules associated a as ass asso BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 6 0 0 0 0 1
[34] [34] [34] [ [3 [34 [34] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 [] 2 10 0 0 0 0 1
, with , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 , 1 2 0 0 0 0 1
expression associated expression e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
[35] [35] [35] [ [3 [35 [35] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 [] 2 10 0 0 0 0 1
. Skin . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 . 1 1 0 0 0 0 1
inflammation suggests inflammation i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
cells cells cells c ce cel cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 1 0 0 0 0 1
[22] [22] [22] [ [2 [22 [22] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 . 1 0 0 0 0 0 1
Gastrin­releasing peptide gastrin­releasing G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 () 2 10 0 0 0 0 1
itch transmitter itch i it itc itch BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 3 0 0 0 0 1
[36] [36] [36] [ [3 [36 [36] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 [] 2 10 0 0 0 0 1
. GRP . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 . 1 6 0 0 0 0 1
transmitter of transmitter t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 () 2 10 0 0 0 0 1
activates the activates a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 () 2 9 0 0 0 0 1
specific to specific s sp spe spec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 no 0 6 0 0 0 0 1
[37] [37] [37] [ [3 [37 [37] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 [] 2 10 0 0 0 0 1
. The . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 . 1 4 0 0 0 0 1
tamate transporter tamate t ta tam tama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 () 2 10 0 0 0 0 1
involved in involved i in inv invo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
[38,39] [38,39] [38,39] [ [3 [38 [38, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 [,] 3 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 . 1 0 0 0 0 0 1
Lysophosphatidic acid lysophosphatidic L Ly Lys Lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 () 2 8 0 0 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 / 1 10 0 0 0 0 1
patients with patients p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 5 0 0 0 0 1
[11,12] [11,12] [11,12] [ [1 [11 [11, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 [,] 3 10 0 0 0 0 1
. LPA . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 . 1 4 0 0 0 0 1
lysophosphatidylcholine (LPC) lysophosphatidylcholine l ly lys lyso BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 ()() 4 10 0 0 0 0 1
[40,41] [40,41] [40,41] [ [4 [40 [40, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 [,] 3 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 . 1 0 0 0 0 0 1
LPA and lpa L LP LPA LPA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
patients, suggesting patients, p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 10 0 0 0 0 1
targets targets targets t ta tar targ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 1 0 0 0 0 1
[11,12,42] [11,12,42] [11,12,42] [ [1 [11 [11, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 [,,] 4 10 0 0 0 0 1
. Serum . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 . 1 7 0 0 0 0 1
increased by increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
to healthy to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 , 1 10 0 0 0 0 1
of intrahepatic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 () 2 8 0 0 0 0 1
[43] . [43] [ [4 [43 [43] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 []. 3 1 0 0 0 0 1
The metabolism the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 8 0 0 0 0 1
cirrhotic livers, cirrhotic c ci cir cirr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 , 1 9 0 0 0 0 1
[44] [44] [44] [ [4 [44 [44] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 [] 2 10 0 0 0 0 1
, , , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 , 1 0 0 0 0 0 1
thereby partly thereby t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 8 0 0 0 0 1
induced pruritus induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 ., 2 10 0 0 0 0 1
G­protein­coupled bile g­protein­coupled G G­ G­p G­pr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 ,, 2 9 0 0 0 0 1
by GPBAR1 by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 , 1 7 0 0 0 0 1
was recently was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 8 0 0 0 0 1
stimulating the stimulating s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 9 0 0 0 0 1
cord cord cord c co cor cord BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 0 0 0 0 0 1
[45] [45] [45] [ [4 [45 [45] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 11 [] 2 10 0 0 0 0 1
. TGR5 . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 11 . 1 9 0 0 0 0 1
receptor potential receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 () 2 10 0 0 0 0 1
pruritus pruritus pruritus p pr pru prur BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 no 0 1 0 0 0 0 1
[46] [46] [46] [ [4 [46 [46] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 [] 2 10 0 0 0 0 1
. Thus . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 11 ., 2 7 0 0 0 0 1
specific to specific s sp spe spec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 ,. 2 10 0 0 0 0 1
3419 3419 3419 3 34 341 3419 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 no 0 1 0 0 0 0 0
May 21, may M Ma May May BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 2 11 , 1 10 0 0 0 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 .. 2 5 0 0 0 0 0
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 . 1 10 0 1 1 1 0
MECHANISM OF mechanism M ME MEC MECH BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
CENTRAL NERVOUS central C CE CEN CENT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
Pruritus also pruritus P Pr Pru Prur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 (). 3 10 0 0 0 0 1
For example, for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
μ­opioid receptor μ­opioid μ μ­ μ­o μ­op BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
[47,48] [47,48] [47,48] [ [4 [47 [47, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 [,] 3 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 0 . 1 0 0 0 0 0 1
The μ­opioid the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 10 0 0 0 0 1
inhibits morphine­induced inhibits i in inh inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 6 0 0 0 0 1
[49] [49] [49] [ [4 [49 [49] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 [] 2 10 0 0 0 0 1
, and , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 0 , 1 3 0 0 0 0 1
pruritus in pruritus p pr pru prur BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
[50] [50] [50] [ [5 [50 [50] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 [] 2 10 0 0 0 0 1
. Plasma . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 1 . 1 1 0 0 0 0 1
concentrations of concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
methionine enkephalin methionine m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 , 1 10 0 0 0 0 1
increased due increased i in inc incr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
[51,52] [51,52] [51,52] [ [5 [51 [51, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 [,] 3 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 1 . 1 0 0 0 0 0 1
The liver the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 10 0 0 0 0 1
derived opioid derived d de der deri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 4 0 0 0 0 1
[53] [53] [53] [ [5 [53 [53] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 [] 2 10 0 0 0 0 1
. These . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 . 1 4 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 9 0 0 0 0 1
pruritus sensations pruritus p pr pru prur BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 10 0 0 0 0 1
[54] [54] [54] [ [5 [54 [54] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 . 1 0 0 0 0 0 1
In contrast, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 2 , 1 8 0 0 0 0 1
suppress pruritus. suppress s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ., 2 9 0 0 0 0 1
(TRK­820) [(E)­N­[17­(cyclopropylmethyl)­4,5α­ (trk­820) ( (T (TR (TRK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 ()[()[(), 9 8 0 0 0 0 1
epoxy­3,14­ dihydroxymorphinan­6β−yl]-3-(furan-3- epoxy­3,14­ e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 ,−]--(-- 8 8 0 0 0 0 1
yl)­N­methylpop­2­enamide monohydrochloride], yl)­n­methylpop­2­enamide y yl yl) yl)­ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 )], 3 8 0 0 0 0 1
shown to shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 10 0 0 0 0 1
mouse model mouse m mo mou mous BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 2 0 0 0 0 1
[54] [54] [54] [ [5 [54 [54] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 [] 2 10 0 0 0 0 1
, whereas , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 , 1 6 0 0 0 0 1
by the by b by by by BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 10 0 0 0 0 1
antagonist nor­binaltorphimine antagonist a an ant anta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 10 0 0 0 0 1
[54] [54] [54] [ [5 [54 [54] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 [] 2 10 0 0 0 0 1
. Nalfurafine . . . . . BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 . 1 4 0 0 0 0 1
found to found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 10 0 0 0 0 1
administration of administration a ad adm admi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
[55] [55] [55] [ [5 [55 [55] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 [] 2 10 0 0 0 0 1
. Similar . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 4 . 1 3 0 0 0 0 1
observed in observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
treatment with treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 (), 3 10 0 0 0 0 1
of expression of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 9 0 0 0 0 1
nitric oxide nitric n ni nit nitr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 () 2 5 0 0 0 0 1
[56] [56] [56] [ [5 [56 [56] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 [] 2 10 0 0 0 0 1
. Nalfurafine . . . . . BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 4 . 1 3 0 0 0 0 1
anti­pruritic activity anti­pruritic a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 , 1 10 0 0 0 0 1
mediated by mediated m me med medi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 4 0 0 0 0 1
[56] [56] [56] [ [5 [56 [56] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 [] 2 10 0 0 0 0 1
. These . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 . 1 4 0 0 0 0 1
that NO that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
κ­receptor action κ­receptor κ κ­ κ­r κ­re BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 3 0 0 0 0 1
[56] [56] [56] [ [5 [56 [56] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 . 1 0 0 0 0 0 1
NO expression no N NO NO NO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 0 0 0 1
and primary and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 9 0 0 0 0 1
contributor to contributor c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
cirrhosis cirrhosis cirrhosis c ci cir cirr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 1 0 0 0 0 1
[16,57] [16,57] [16,57] [ [1 [16 [16, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 [,] 3 10 0 0 0 0 1
. NO . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 . 1 6 0 0 0 0 1
P­induced scratching p­induced P P­ P­i P­in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 , 1 9 0 0 0 0 1
synthase inhibitor synthase s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
dependent manner dependent d de dep depe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 3 0 0 0 0 1
[58] [58] [58] [ [5 [58 [58] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 [] 2 10 0 0 0 0 1
. NO . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 6 . 1 10 0 0 0 0 1
[59] [59] [59] [ [5 [59 [59] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 [] 2 10 0 0 0 0 1
, , , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 6 , 1 0 0 0 0 0 1
suggesting it suggesting s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
contribution of contribution c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 0 0 0 0 1
and requires and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
κ receptors κ κ κ κ κ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
peripheral nerves peripheral p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 8 0 0 0 0 1
of pruritus of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 2 0 0 0 0 1
[60,61] . [60,61] [ [6 [60 [60, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 [,]. 4 7 0 0 0 0 1
are complicated are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 7 0 0 0 0 1
3420 3420 3420 3 34 342 3420 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 7 no 0 1 0 0 0 0 0
May 21, may M Ma May May BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 2 7 , 1 10 0 0 0 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 .. 2 5 0 0 0 0 0
Periphery Periphery periphery P Pe Per Peri BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 10 1 1 0 0 1
Blood flow blood B Bl Blo Bloo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 10 1 0 0 0 1
increase increase increase i in inc incr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 8 1 0 0 0 1
Substance P substance S Su Sub Subs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 10 1 0 0 0 1
Mast cell mast M Ma Mas Mast BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 7 no 0 10 1 0 0 0 1
Bile acid bile B Bi Bil Bile BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Histamine Histamine histamine H Hi His Hist BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
LPC LPC lpc L LP LPC LPC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
LPA LPA lpa L LP LPA LPA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
ATX ATX atx A AT ATX ATX BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Cytokines Cytokines cytokines C Cy Cyt Cyto BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Immune cell immune I Im Imm Immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
Mechanical stimuli mechanical M Me Mec Mech BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
receptor receptor receptor r re rec rece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 4 1 0 0 0 1
Scratching Scratching scratching S Sc Scr Scra BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
C-fiber C-fiber c-fiber C C- C-f C-fi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 - 1 8 0 0 0 0 1
GRP GRP grp G GR GRP GRP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 4 0 0 0 0 1
Thalamus Thalamus thalamus T Th Tha Thal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
A-fiber A-fiber a-fiber A A- A-f A-fi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 - 1 10 1 0 0 0 1
Spinal Spinal spinal S Sp Spi Spin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
cord cord cord c co cor cord BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 7 1 0 0 0 1
Cerebral Cerebral cerebral C Ce Cer Cere BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
cortex cortex cortex c co cor cort BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 7 1 0 0 0 1
Pain Pain pain P Pa Pai Pain BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
Touch Touch touch T To Tou Touc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 1 0 0 0 1
Pruritus Pruritus pruritus P Pr Pru Prur BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 6 0 0 0 0 1
GRPR GRPR grpr G GR GRP GRPR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 3 0 0 0 0 1
DRG DRG drg D DR DRG DRG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 2 0 0 0 0 1
Itch receptor itch I It Itc Itch BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
TRPV1 TRPV1 trpv1 T TR TRP TRPV BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 no 0 8 0 0 0 0 1
VGLUT2 VGLUT2 vglut2 V VG VGL VGLU BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
H1, H4 h1, H H1 H1, H1, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 , 1 8 0 0 0 0 1
TRPV1 TRPV1 trpv1 T TR TRP TRPV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 no 0 7 0 0 0 0 1
PAR2, 4 par2, P PA PAR PAR2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 , 1 10 0 0 0 0 1
MrgA3 MrgA3 mrga3 M Mr Mrg MrgA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 no 0 7 0 0 0 0 1
TGR5 TGR5 tgr5 T TG TGR TGR5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 no 0 6 0 0 0 0 1
Central nervous central C Ce Cen Cent BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 10 1 1 0 0 1
NO NO no N NO NO NO BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 10 1 0 0 0 1
μ receptor μ μ μ μ μ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 1 0 0 0 1
κ receptor κ κ κ κ κ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 1 0 0 0 1
Enkephalin Enkephalin enkephalin E En Enk Enke BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 9 1 0 0 0 1
β-endorphin β-endorphin β-endorphin β β- β-e β-en BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 - 1 10 1 0 0 0 1
Dynorphin Dynorphin dynorphin D Dy Dyn Dyno BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 1 0 0 0 1
Figure 1 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 .,,, 4 9 1 0 0 0 1
receptors. Itch receptors. r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 .-. 3 10 1 0 0 0 1
periphery nerve periphery p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,..- 4 10 1 0 0 0 1
to secrete to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,.:;:;:;:;:- 12 9 1 0 0 0 1
peptide; GRPR: peptide; p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 ;:-;:;:-;: 10 9 1 0 0 0 1
Mrg subtype mrg M Mr Mrg Mrg BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ;:--;:. 7 6 1 0 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 . 1 10 1 1 1 0 0
3421 3421 3421 3 34 342 3421 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 0
May 21, may M Ma May May BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 2 0 , 1 10 0 0 1 1 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 .. 2 5 0 0 0 0 0
BRIC is bric B BR BRI BRIC BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
pruritus, and pruritus, p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ,, 2 9 0 1 0 0 1
last from last l la las last BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 1 0 0 1
spontaneously spontaneously spontaneously s sp spo spon BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 2 0 1 0 0 1
[75,76] [75,76] [75,76] [ [7 [75 [75, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 [,] 3 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 . 1 0 0 0 0 0 1
Benign obstructive benign B Be Ben Beni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
a lower a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 0 . 1 10 0 0 0 0 1
example, pruritus example, e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
benign biliary benign b be ben beni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
but in but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
such as such s su suc such BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 7 0 0 0 0 1
[77] [77] [77] [ [7 [77 [77] BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 . 1 10 0 0 0 0 1
TREATMENT OF treatment T TR TRE TREA BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 10 0 0 0 0 1
The guidelines the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
Study of study S St Stu Stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 () 2 8 0 0 0 0 1
Association for association A As Ass Asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 () 2 9 0 0 0 0 1
criteria for criteria c cr cri crit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 10 0 0 0 0 1
patients with patients p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 4 0 0 0 0 1
[78,79] [78,79] [78,79] [ [7 [78 [78, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 [,] 3 10 0 0 0 0 1
. Recommendations . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 . 1 3 0 0 0 0 1
all patients all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 10 0 0 0 0 1
cooling ointments cooling c co coo cool BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
avoid secondary avoid a av avo avoi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 . 1 9 0 0 0 0 1
treatment include treatment t tr tre trea BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
[5] [5] [5] [ [5 [5] [5] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 [] 2 10 0 0 0 0 1
: (1) : : : : : BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 2 :() 3 6 0 0 0 0 1
as cholestyramine as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
of cholestasis; of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ;() 3 8 0 0 0 0 1
of presumed of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ;() 3 8 0 0 0 0 1
modulation of modulation m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
acting agents; acting a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ;() 3 10 0 0 0 0 1
by anion by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 , 1 9 0 0 0 0 1
albumin dialysis albumin a al alb albu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (). 3 5 0 0 0 0 1
Ursodeoxycholic acid ursodeoxycholic U Ur Urs Urso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 () 2 8 0 0 0 0 1
drug for drug d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 6 0 0 0 0 1
[80,81] . [80,81] [ [8 [80 [80, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 [,]. 4 1 0 0 0 0 1
Although associated although A Al Alt Alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
improvements and improvements i im imp impr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 7 0 0 0 0 1
[80,81] [80,81] [80,81] [ [8 [80 [80, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 [,] 3 10 0 0 0 0 1
, , , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 , 1 0 0 0 0 0 1
UDCA was udca U UD UDC UDCA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
both PBC both b bo bot both BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 2 0 0 0 0 1
[66,82] [66,82] [66,82] [ [6 [66 [66, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 [,] 3 10 0 0 0 0 1
. In . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 .,, 3 6 0 0 0 0 1
UDCA not udca U UD UDC UDCA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
aspartate aminotransferase aspartate a as asp aspa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 9 0 0 0 0 1
concentrations, but concentrations, c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 7 0 0 0 0 1
[74,83] [74,83] [74,83] [ [7 [74 [74, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 [,] 3 10 0 0 0 0 1
. UDCA . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 . 1 1 0 0 0 0 1
is used is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
of bile of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 10 0 0 0 0 1
expected to expected e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 9 0 0 0 0 1
BRIC BRIC bric B BR BRI BRIC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 0 0 0 0 0 1
[75] [75] [75] [ [7 [75 [75] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 4 . 1 0 0 0 0 0 1
Cholestyramine, a cholestyramine, C Ch Cho Chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 ,, 2 8 0 0 0 0 1
commended as commended c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 0 0 0 0 1
with cholestatic with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 10 0 0 0 0 1
randomized studies randomized r ra ran rand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 8 0 0 0 0 1
(eight and (eight ( (e (ei (eig BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 (,) 3 5 0 0 0 0 1
[84,85] [84,85] [84,85] [ [8 [84 [84, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 [,] 3 10 0 0 0 0 1
. Although . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 4 . 1 3 0 0 0 0 1
well­tolerated, cholestyramine well­tolerated, w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 , 1 8 0 0 0 0 1
effects, including effects, e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ,,, 3 10 0 0 0 0 1
constipation, anorexia constipation, c co con cons BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 9 0 0 0 0 1
[86] [86] [86] [ [8 [86 [86] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 5 . 1 0 0 0 0 0 1
A meta­analysis a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
control trials control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
X receptor x X X X X BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 5 () 2 9 0 0 0 0 1
mycobacterial infection, mycobacterial m my myc myco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 10 0 0 0 0 1
chronic pruritus chronic c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 3 0 0 0 0 1
[87] . [87] [ [8 [87 [87] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 []. 3 6 0 0 0 0 1
duce ATX duce d du duc duce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
mechanism mechanism mechanism m me mec mech BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 1 0 0 0 0 1
[42] [42] [42] [ [4 [42 [42] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 [] 2 10 0 0 0 0 1
. Although . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 5 . 1 7 0 0 0 0 1
of chronic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
hepatotoxicity in hepatotoxicity h he hep hepa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
especially in especially e es esp espe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 9 0 1 0 0 1
making understanding making m ma mak maki BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 9 0 1 0 0 1
in these in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 6 no 0 10 0 1 0 0 1
to treatment. to t to to to BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 2 0 1 0 0 1
PREVALENCE AND prevalence P PR PRE PREV BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
PRURITUS IN pruritus P PR PRU PRUR BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
Chronic cholestatic chronic C Ch Chr Chro BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
Primary biliary primary P Pr Pri Prim BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 (), 3 8 0 0 0 0 1
primary biliary primary p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 9 0 0 0 0 1
cholestatic liver cholestatic c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 . 1 10 0 0 0 0 1
is found is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 7 0 0 0 0 1
[2,62] and [2,62] [ [2 [2, [2,6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 [,] 3 1 0 0 0 0 1
precedes the precedes p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 7 0 0 0 0 1
[62] . [62] [ [6 [62 [62] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 []. 3 1 0 0 0 0 1
Pruritus has pruritus P Pr Pru Prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 , 1 9 0 0 0 0 1
as sleep, as a as as as BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 5 0 0 0 0 1
[62,63] [62,63] [62,63] [ [6 [62 [62, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 [,] 3 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 7 . 1 0 0 0 0 0 1
Primary sclerosing primary P Pr Pri Prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 () 2 9 0 0 0 0 1
ciated with ciated c ci cia ciat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 8 0 0 0 0 1
progression. In progression. p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 ., 2 10 0 0 0 0 1
are asymptomatic are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 ; 1 9 0 0 0 0 1
the exact the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 9 0 0 0 0 1
remains unclear remains r re rem rema BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 2 0 0 0 0 1
[64] [64] [64] [ [6 [64 [64] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 . 1 0 0 0 0 0 1
Pruritus in pruritus P Pr Pru Prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 8 0 0 0 0 1
frequently in frequently f fr fre freq BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 10 0 0 0 0 1
soles soles soles s so sol sole BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
[1,65] [1,65] [1,65] [ [1 [1, [1,6 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 [,] 3 10 0 0 0 0 1
. Multivariate . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 . 1 7 0 0 0 0 1
alkaline phosphatase alkaline a al alk alka BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
independent predictors independent i in ind inde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 9 0 0 0 0 1
PBC PBC pbc P PB PBC PBC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 0 0 0 0 0 1
[66] [66] [66] [ [6 [66 [66] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 [] 2 10 0 0 0 0 1
. Severe . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 . 1 8 0 0 0 0 1
causes fatigue, causes c ca cau caus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,, 2 10 0 0 0 0 1
becoming an becoming b be bec beco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
patients patients patients p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
[8,67,68] [8,67,68] [8,67,68] [ [8 [8, [8,6 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 [,,] 4 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 . 1 10 0 0 0 0 1
Chronic hepatitis chronic C Ch Chr Chro BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
Pruritus was pruritus P Pr Pru Prur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 () 2 10 0 0 0 0 1
chronic hepatitis chronic c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 () 2 9 0 0 0 0 1
hepatitis C hepatitis h he hep hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 2 0 0 0 0 1
[69] . [69] [ [6 [69 [69] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 []. 3 7 0 0 0 0 1
the proportion the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 9 0 0 0 0 1
ranged from ranged r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 6 0 0 0 0 1
[70] to [70] [ [7 [70 [70] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 [] 2 3 0 0 0 0 1
patients patients patients p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
[71] [71] [71] [ [7 [71 [71] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 [] 2 10 0 0 0 0 1
. Pruritus . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 . 1 10 0 0 0 0 1
by cholestasis by b by by by BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 3 0 0 0 0 1
[70] [70] [70] [ [7 [70 [70] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 [] 2 10 0 0 0 0 1
, whereas , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 , 1 8 0 0 0 0 1
was a was w wa was was BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
[71] [71] [71] [ [7 [71 [71] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 . 1 10 0 0 0 0 1
Other cholestatic other O Ot Oth Othe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
Pruritus is pruritus P Pr Pru Prur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 10 no 0 9 0 0 0 0 1
lestasis of lestasis l le les lest BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 (), 3 10 0 0 0 0 1
by increases by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 9 0 0 0 0 1
increased rates increased i in inc incr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 7 0 0 0 0 1
[72] [72] [72] [ [7 [72 [72] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 [] 2 10 0 0 0 0 1
. Pruritus . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 . 1 2 0 0 0 0 1
in ICP in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
[73] [73] [73] [ [7 [73 [73] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 . 1 0 0 0 0 0 1
The incidence the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 ., 2 9 0 0 0 0 1
increased fetal increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
acid concentrations acid a ac aci acid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 4 0 0 0 0 1
[74] [74] [74] [ [7 [74 [74] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 . 1 0 0 0 0 0 1
Familial intrahepatic familial F Fa Fam Fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 , 1 9 0 0 0 0 1
recurrent intrahepatic recurrent r re rec recu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 (), 3 8 0 0 0 0 1
autosomal recessive autosomal a au aut auto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 9 0 0 0 0 1
licular transport licular l li lic licu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 9 0 0 0 0 1
in ATP8B1, in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 11 ,. 2 8 0 0 0 0 1
ranging from ranging r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 10 0 0 0 0 1
cholestasis according cholestasis c ch cho chol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 8 0 0 0 0 1
[75] [75] [75] [ [7 [75 [75] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 . 1 10 0 0 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 . 1 10 0 1 1 0 0
3422 3422 3422 3 34 342 3422 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 0
May 21, may M Ma May May BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 4 0 , 1 10 0 0 1 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .. 2 5 0 0 0 0 0
for several for f fo for for BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 5 0 0 0 0 1
[88] . [88] [ [8 [88 [88] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 []. 3 4 0 0 0 0 1
that may that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
nausea, loss nausea, n na nau naus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,,, 3 9 0 0 0 0 1
failure and failure f fa fai fail BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 5 0 0 0 0 1
[87,89] [87,89] [87,89] [ [8 [87 [87, BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 [,] 3 10 0 0 0 0 1
. Careful . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 . 1 3 0 0 0 0 1
of blood of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
during administration during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
pruritus, and pruritus, p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 10 0 0 0 0 1
recommended recommended recommended r re rec reco BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 2 0 0 0 0 1
[90] [90] [90] [ [9 [90 [90] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 . 1 0 0 0 0 0 1
Prospective placebo­controlled prospective P Pr Pro Pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
μ­opioid receptor μ­opioid μ μ­ μ­o μ­op BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
in treating in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 no 0 5 0 0 0 0 1
[91­94] . [91­94] [ [9 [91 [91­ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 []. 3 3 0 0 0 0 1
effects of effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
reactions, particularly reactions, r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 10 0 0 0 0 1
Contraindications to contraindications C Co Con Cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
injury and injury i in inj inju BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 10 0 0 0 0 1
should be should s sh sho shou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
and those and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
[95] [95] [95] [ [9 [95 [95] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 1 . 1 0 0 0 0 0 1
In Japan, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 1 ,,, 3 9 0 0 0 0 1
available for available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 10 0 0 0 0 1
diseases (2.5­5 diseases d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 (./). 5 8 0 0 0 0 1
predominantly by predominantly p pr pre pred BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 5 0 0 0 0 1
[96] [96] [96] [ [9 [96 [96] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 [] 2 10 0 0 0 0 1
, but , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 2 , 1 2 0 0 0 0 1
metabolite has metabolite m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 , 1 10 0 0 0 0 1
its availability its i it its its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 9 0 0 0 0 1
patients with patients p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 6 0 0 0 0 1
[97] [97] [97] [ [9 [97 [97] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 [] 2 10 0 0 0 0 1
. Recently . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 2 . 1 2 0 0 0 0 1
randomized controlled randomized r ra ran rand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 no 0 9 0 0 0 0 1
nalfurafine by nalfurafine n na nal nalf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 (./) 4 10 0 0 0 0 1
pruritus with pruritus p pr pru prur BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 no 0 6 0 0 0 0 1
[98] [98] [98] [ [9 [98 [98] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 2 . 1 0 0 0 0 0 1
Sertraline, a sertraline, S Se Ser Sert BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 , 1 9 0 0 0 0 1
(SSRI), is (ssri), ( (S (SS (SSR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 (), 3 10 0 0 0 0 1
with cholestatic with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 .(/) 4 9 0 0 0 0 1
was well­tolerated was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 9 0 0 0 0 1
effects in effects e ef eff effe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 9 0 0 0 0 1
patients patients patients p pa pat pati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 10 0 1 0 0 1
[99] [99] [99] [ [9 [99 [99] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 [] 2 10 0 1 0 0 1
. Because . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 3 . 1 7 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 3 ,(.., 5 10 0 1 0 0 1
frequent dosing) frequent f fr fre freq BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ) 1 8 0 1 0 0 1
with advanced with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 . 1 9 0 1 0 0 1
administered to administered a ad adm admi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 8 0 1 0 0 1
oxidase inhibitors oxidase o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 8 0 1 0 0 1
concurrently taking concurrently c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 , 1 8 0 1 0 0 1
concentrate should concentrate c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 1 0 0 1
disulfiram disulfiram disulfiram d di dis disu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 1 0 1 0 0 1
[90] [90] [90] [ [9 [90 [90] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 4 . 1 0 0 0 0 0 1
The AASLD the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 0 0 0 1
that patients that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 0 0 0 1
standard therapies standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 0 0 0 0 1
approaches. Case approaches. a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 . 1 10 0 0 0 0 1
such as such s su suc such BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 4 0 0 0 0 1
[100,101] [100,101] [100,101] [ [1 [10 [100 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 4 [,] 3 10 0 0 0 0 1
, albumin , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 4 , 1 5 0 0 0 0 1
molecular absorbent molecular m mo mol mole BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 () 2 10 0 0 0 0 1
[102­104] [102­104] [102­104] [ [1 [10 [102 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 [] 2 10 0 0 0 0 1
, , , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 4 , 1 0 0 0 0 0 1
plasma separation plasma p pl pla plas BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 10 0 0 0 0 1
[105] [105] [105] [ [1 [10 [105 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 [] 2 10 0 0 0 0 1
, ultraviolet , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 5 , 1 2 0 0 0 0 1
B phototherapy b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 5 no 0 2 0 0 0 0 1
[106] , [106] [ [1 [10 [106 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 [], 3 5 0 0 0 0 1
[107] and [107] [ [1 [10 [107 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 [] 2 1 0 0 0 0 1
surgical intervention surgical s su sur surg BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 10 0 0 0 0 1
[75] [75] [75] [ [7 [75 [75] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 5 . 1 0 0 0 0 0 1
Little evidence little L Li Lit Litt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 0 0 0 1
these approaches, these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
prior to prior p pr pri prio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
recommended by recommended r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
except for except e ex exc exce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
ever, rifampicin ever, e ev eve ever BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
than 2 than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
chronic liver chronic c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,, 2 10 0 0 0 0 1
modalities tolerable modalities m mo mod moda BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 8 0 0 0 0 1
A large­scale a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 5 (), 3 8 0 0 0 0 1
showed that showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
hemodialysis patients hemodialysis h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 9 0 0 0 0 1
to conventional to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 4 0 0 0 0 1
[108] and [108] [ [1 [10 [108 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 [] 2 5 0 0 0 0 1
was tolerable was w wa was was BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 4 0 0 0 0 1
[109] [109] [109] [ [1 [10 [109 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 [] 2 10 0 0 0 0 1
. Its . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 6 . 1 5 0 0 0 0 1
pruritus in pruritus p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 10 0 0 0 0 1
shown by shown s sh sho show BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 () 2 8 0 0 0 0 1
[98] [98] [98] [ [9 [98 [98] BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 [] 2 10 0 0 0 0 1
. . . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 7 . 1 0 0 0 0 0 1
Its tolerability its I It Its Its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 . 1 10 0 0 0 0 1
and tolerability and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 8 0 0 0 0 1
are desired. are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 . 1 2 0 0 0 0 1
Recent studies recent R Re Rec Rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 8 0 0 0 0 1
nuclear receptors nuclear n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 , 1 9 0 0 0 0 1
with farnesoid with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 () 2 9 0 0 0 0 1
acid synthesis acid a ac aci acid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 2 0 0 0 0 1
[110,111] [110,111] [110,111] [ [1 [11 [110 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 7 [,] 3 10 0 0 0 0 1
. Obeticolic . . . . . BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 7 .,, 3 6 0 0 0 0 1
showed significant showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 9 0 0 0 0 1
parameters, but parameters, p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 , 1 7 0 0 0 0 1
[112] . [112] [ [1 [11 [112 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 []. 3 2 0 0 0 0 1
incidence and incidence i in inc inci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
be independent be b be be be BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 6 0 0 0 0 1
[113,114] [113,114] [113,114] [ [1 [11 [113 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 8 [,] 3 10 0 0 0 0 1
, and , , , , , BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 8 , 1 1 0 0 0 0 1
mechanism of mechanism m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 10 0 0 0 0 1
The effect the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
evaluated. evaluated. evaluated. e ev eva eval BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 2 0 0 0 0 1
CONCLUSION CONCLUSION conclusion C CO CON CONC BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
The mechanism the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
diseases is diseases d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 9 0 0 0 0 1
periphery and periphery p pe per peri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
complicate determinations complicate c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
treatment strategies. treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 9 0 0 0 0 1
patients with patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 , 1 10 0 0 0 0 1
with chronic with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 , 1 10 0 0 0 0 1
Pruritus Pruritus pruritus P Pr Pru Prur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 10 0 1 0 0 1
Bile duct bile B Bi Bil Bile BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 10 0 1 0 0 1
Present Present present P Pr Pre Pres BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
Absent Absent absent A Ab Abs Abse BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 8 0 0 0 0 1
Evidence level evidence E Ev Evi Evid BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 9 no 0 2 0 0 0 0 1
st line st s st st st BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
2 2 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 9 no 0 2 0 0 0 0 1
nd line nd n nd nd nd BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
3 3 3 3 3 3 3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 9 no 0 2 0 0 0 0 1
rd line rd r rd rd rd BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 9 no 0 2 0 0 0 0 1
th line th t th th th BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
5 5 5 5 5 5 5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 9 no 0 2 0 0 0 0 1
th line th t th th th BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
Biliary drainage biliary B Bi Bil Bili BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 6 0 0 0 0 1
Cholestyramine (4-16 cholestyramine C Ch Cho Chol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 (-/) 4 10 0 0 0 0 1
Rifampicin (150-300 rifampicin R Ri Rif Rifa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 (-) 3 10 0 0 0 0 1
Naltrexone (50 naltrexone N Na Nal Nalt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 () 2 10 0 0 0 0 1
Sertraline (75-100 sertraline S Se Ser Sert BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 (-) 3 10 0 0 0 0 1
Experimental approach experimental E Ex Exp Expe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 10 0 0 0 0 1
II-2/B II-2/B ii-2/b I II II- II-2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 -/ 2 10 0 0 0 0 1
I/A I/A i/a I I/ I/A I/A BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 / 1 10 0 0 0 0 1
I/B I/B i/b I I/ I/B I/B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 / 1 10 0 0 0 0 1
II-2/C II-2/C ii-2/c I II II- II-2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 -/ 2 10 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 9 - 1 10 0 0 0 0 1
Figure 2 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 7 0 0 0 0 1
cholestatic pruritus cholestatic c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 8 0 0 0 0 1
Liver Diseases liver L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 9 0 0 0 0 1
and evidence and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 .:, 3 9 0 0 0 0 1
trials; II-1 trials; t tr tri tria BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ;-;-,- 6 10 0 0 0 0 1
analytic studies; analytic a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ;-,,; 5 9 0 0 0 0 1
and III, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ,,. 3 9 0 0 0 0 1
grading includes grading g gr gra grad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 :, 2 9 0 0 0 0 1
change confidence change c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ;:, 3 9 0 0 0 0 1
further research further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 9 0 0 0 0 1
of effect of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ;:, 3 9 0 0 0 0 1
further research further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 9 0 0 0 0 1
the estimation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 9 0 0 0 0 1
estimate is estimate e es est esti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 2 0 0 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 . 1 10 0 1 1 0 0
3423 3423 3423 3 34 342 3423 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 0 0 0 0
May 21, may M Ma May May BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 5 0 , 1 10 0 0 1 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 .. 2 5 0 0 0 0 0
quality of quality q qu qua qual BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 1 0 0 1
pruritus are pruritus p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ,, 2 10 0 1 0 0 1
therapeutic options therapeutic t th the ther BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 6 0 1 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Bergasa NV, bergasa B Be Ber Berg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,. 3 8 0 0 0 0 1
in primary in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 . 1 8 0 0 0 0 1
Gastroenterol 2000; gastroenterol G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ;:-[::./ 8 9 0 0 0 0 1
bega.2000.0109] bega.2000.0109] bega.2000.0109] b be beg bega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ..] 3 2 0 0 0 0 1
2 2 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Koulentaki M, koulentaki K Ko Kou Koul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,,, 4 7 0 0 0 0 1
Drigiannakis I, drigiannakis D Dr Dri Drig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,,, 4 8 0 0 0 0 1
EA. Dermatological ea. E EA EA. EA. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
patients: a patients: p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :.;: 4 9 0 0 0 0 1
541-546 [PMID: 541-546 5 54 541 541- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -[::./.-...] 12 9 0 0 0 0 1
3 3 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Younossi ZM, younossi Y Yo You Youn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,,,. 5 7 0 0 0 0 1
Cholestatic liver cholestatic C Ch Cho Chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 -. 2 10 0 0 0 0 1
Gastroenterol 2000; gastroenterol G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ;:-[::./ 8 9 0 0 0 0 1
j.1572-0241.2000.01774.x] j.1572-0241.2000.01774.x] j.1572-0241.2000.01774.x] j j. j.1 j.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 .-...] 6 3 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Kremer AE, kremer K Kr Kre Krem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,-,. 5 8 0 0 0 0 1
and treatment and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .;:- 4 10 0 0 0 0 1
[PMID: 18840005] [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 [:] 3 2 0 0 0 0 1
5 5 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Kremer AE, kremer K Kr Kre Krem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,,,, 5 8 0 0 0 0 1
Beuers U. beuers B Be Beu Beue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 8 0 0 0 0 1
PSC. Dig psc. P PS PSC PSC. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 .;:-[:: 7 8 0 0 0 0 1
10.1159/000440829] 10.1159/000440829] 10.1159/000440829] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ./] 3 2 0 0 0 0 1
6 6 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Bergasa NV. bergasa B Be Ber Berg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ..;: 4 8 0 0 0 0 1
1078-1088 [PMID: 1078-1088 1 10 107 1078 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 -[::./....] 11 8 0 0 0 0 1
7 7 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Jin XY, jin J Ji Jin Jin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 0 ,. 2 9 0 0 0 0 1
cholestatic liver cholestatic c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -:. 3 9 0 0 0 0 1
Formos Med formos F Fo For Form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ;:-[:: 6 8 0 0 0 0 1
10.1016/j.jfma.2016.05.006] 10.1016/j.jfma.2016.05.006] 10.1016/j.jfma.2016.05.006] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ./....] 7 4 0 0 0 0 1
8 8 8 8 8 8 8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Elias E, elias E El Eli Elia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 0 ,.:. 4 10 0 0 0 0 1
J Gastroenterol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 ;:-[:] 6 8 0 0 0 0 1
9 9 9 9 9 9 9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 0 0 0 0 0 1
Elias E. elias E El Eli Elia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 0 ..;: 4 9 0 0 0 0 1
224-232 [PMID: 224-232 2 22 224 224- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -[:] 4 3 0 0 0 0 1
10 Quist 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,-,,,. 6 8 0 0 0 0 1
Activation of activation A Ac Act Acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 .;: 3 10 0 0 0 0 1
446-456 [PMID: 446-456 4 44 446 446- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -[:] 4 3 0 0 0 0 1
11 Kremer 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,,,,, 5 8 0 0 0 0 1
Buuren HR, buuren B Bu Buu Buur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,,, 4 8 0 0 0 0 1
C, Geenes c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,,,, 5 8 0 0 0 0 1
Elferink RP. elferink E El Elf Elfe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
cholestatic pruritus. cholestatic c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 .;:-,. 6 9 0 0 0 0 1
e1 [PMID: e1 e e1 e1 e1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 [::./....] 10 7 0 0 0 0 1
12 Oude 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,,,. 4 8 0 0 0 0 1
molecular mechanism molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .;: 3 9 0 0 0 0 1
66-71 [PMID: 66-71 6 66 66- 66-7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -[::./] 7 6 0 0 0 0 1
13 Spivey 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,,,.- 5 8 0 0 0 0 1
enkephalin concentrations enkephalin e en enk enke BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
not pruritus not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
Gastroenterol 1994; gastroenterol G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ;:-[:] 6 7 0 0 0 0 1
14 Bergasa 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,,,,, 5 8 0 0 0 0 1
Turner ML, turner T Tu Tur Turn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 0 ,,.- 4 8 0 0 0 0 1
nalmefene therapy nalmefene n na nal nalm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 .; 2 10 0 0 0 0 1
27: 679-684 27: 2 27 27: 27: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 :-[::./.] 9 8 0 0 0 0 1
15 Bergasa 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,,,,. 5 9 0 0 0 0 1
nalmefene therapy nalmefene n na nal nalm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
of cholestasis: of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :.;: 4 9 0 0 0 0 1
431-434 [PMID: 431-434 4 43 431 431- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -[:] 4 3 0 0 0 0 1
16 Vallance 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,.: 3 9 0 0 0 0 1
role for role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ?;:-[:] 7 9 0 0 0 0 1
17 Andrew 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,. 2 9 0 0 0 0 1
sensitive to sensitive s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :. 2 9 0 0 0 0 1
Neurosci 2001; neurosci N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ;:-[::./] 9 8 0 0 0 0 1
18 Schmelz 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ..;:- 5 10 0 0 0 0 1
[PMID: 11135635 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 [::./] 6 5 0 0 0 0 1
19 Patel 19 1 19 19 19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 ,..;: 5 9 0 0 0 0 1
334-339 [PMID: 334-339 3 33 334 334- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -[::./....] 11 8 0 0 0 0 1
20 Braz 20 2 20 20 20 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,. 4 9 0 1 0 0 1
itch messages: itch i it itc itch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 : 1 9 0 1 0 0 1
generate gate generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .;:-[: 6 9 0 1 0 0 1
DOI: 10.1016/j.neuron.2014.01.018] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 :./....] 8 4 0 1 0 0 1
21 LaMotte 21 2 21 21 21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,. 3 7 0 1 0 0 1
circuits mediating circuits c ci cir circ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .;:-[: 6 9 0 1 0 0 1
24356071 DOI: 24356071 2 24 243 2435 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./] 4 4 0 1 0 0 1
22 Ikoma 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,. 5 9 0 1 0 0 1
neurobiology of neurobiology n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .;:-[: 6 8 0 1 0 0 1
16791143 DOI: 16791143 1 16 167 1679 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./] 4 4 0 1 0 0 1
23 Yamaoka 23 2 23 23 23 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,. 4 8 0 1 0 0 1
sensory nerve sensory s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -. 2 8 0 1 0 0 1
Dermatol Sci dermatol D De Der Derm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ;:-[::./ 8 8 0 1 0 0 1
j.jdermsci.2006.12.007] j.jdermsci.2006.12.007] j.jdermsci.2006.12.007] j j. j.j j.jd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 ....] 5 3 0 1 0 0 1
24 Bell 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,. 3 9 0 1 0 0 1
H1 receptors h1 H H1 H1 H1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 no 0 9 0 1 0 0 1
in Balb in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 5 .;:-[: 6 8 0 1 0 0 1
15066908 DOI: 15066908 1 15 150 1506 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./..] 6 5 0 1 0 0 1
25 Han 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,. 3 8 0 1 0 0 1
the scratching the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 1 0 0 1
C-fiber nociceptive c-fiber C C- C-f C-fi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 -.;:-[: 7 8 0 1 0 0 1
17114052 DOI: 17114052 1 17 171 1711 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./....] 8 6 0 1 0 0 1
26 Imamachi 26 2 26 26 26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,, 5 8 0 1 0 0 1
AI, Han ai, A AI AI, AI, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,.- 3 7 0 1 0 0 1
behavioral responses behavioral b be beh beha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 . 1 9 0 1 0 0 1
Natl Acad natl N Na Nat Natl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ;:-[: 5 8 0 1 0 0 1
DOI: 10.1073/pnas.0905605106] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 :./.] 5 4 0 1 0 0 1
27 Reddy 27 2 27 27 27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,. 5 8 0 1 0 0 1
Cowhage-evoked itch cowhage-evoked C Co Cow Cowh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 -: 2 9 0 1 0 0 1
ligand of ligand l li lig liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 -.;:- 5 10 0 1 0 0 1
[PMID: 18434511 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 [::./.-.] 9 7 0 1 0 0 1
28 Dai 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,, 5 8 0 1 0 0 1
Yamanaka H, yamanaka Y Ya Yam Yama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,,.- 4 7 0 1 0 0 1
receptor 2-mediated receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 - 1 9 0 1 0 0 1
vanilloid subfamily vanilloid v va van vani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 - 1 9 0 1 0 0 1
induced inflammatory induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .;:- 4 8 0 1 0 0 1
[PMID: 15128843 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 [::./.-.] 9 7 0 1 0 0 1
29 Amadesi 29 2 29 29 29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,,, 6 9 0 1 0 0 1
Manni C, manni M Ma Man Mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,, 5 8 0 1 0 0 1
EA, Bunnett ea, E EA EA, EA, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,.- 3 8 0 1 0 0 1
capsaicin receptor capsaicin c ca cap caps BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 no 0 9 0 1 0 0 1
to induce to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .;:-[: 6 8 0 1 0 0 1
15128844 DOI: 15128844 1 15 151 1512 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./.-.] 7 6 0 1 0 0 1
30 Carstens 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,. 4 8 0 1 0 0 1
neurons expressing neurons n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 -. 2 8 0 1 0 0 1
Neuroreport 2010; neuroreport N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ;:-[::./ 8 8 0 1 0 0 1
WNR.0b013e328337310a] WNR.0b013e328337310a] wnr.0b013e328337310a] W WN WNR WNR. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 .] 2 3 0 1 0 0 1
31 Liu 31 3 31 31 31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,,,, 7 8 0 1 0 0 1
Guan Y, guan G Gu Gua Guan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,,, 6 7 0 1 0 0 1
Anderson DJ, anderson A An And Ande BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 5 ,.- 3 8 0 1 0 0 1
are itch are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -. 2 8 0 1 0 0 1
Cell 2009; cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 ;:-[::./ 8 7 0 1 0 0 1
j.cell.2009.11.034] j.cell.2009.11.034] j.cell.2009.11.034] j j. j.c j.ce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 ....] 5 2 0 1 0 0 1
32 Han 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,,,,, 8 9 0 1 0 0 1
L, Patel l, L L, L, L, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,,,,, 8 8 0 1 0 0 1
Dong X. dong D Do Don Dong BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 5 .. 2 9 0 1 0 0 1
Nat Neurosci nat N Na Nat Nat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 5 ;:-[::./ 8 8 0 1 0 0 1
nn.3289] nn.3289] nn.3289] n nn nn. nn.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .] 2 1 0 1 0 0 1
33 Harvima 33 3 33 33 33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,. 4 8 0 1 0 0 1
role for role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ?;: 3 8 0 1 0 0 1
461-478 [PMID: 461-478 4 46 461 461- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 -[::./---] 10 7 0 1 0 0 1
34 Chung 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,. 5 8 0 1 0 0 1
and TRPV4 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 - 1 8 0 1 0 0 1
keratinocytes. J keratinocytes. k ke ker kera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .;:-[: 6 8 0 1 0 0 1
15004014 DOI: 15004014 1 15 150 1500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./.] 5 5 0 1 0 0 1
35 Yoshioka 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,,,,, 5 9 0 1 0 0 1
T, Sakata t, T T, T, T, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,,,. 4 8 0 1 0 0 1
substitution in substitution s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 1 0 0 1
dermatitis in dermatitis d de der derm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .;:-[: 6 9 0 1 0 0 1
18754035 DOI: 18754035 1 18 187 1875 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 5 :./..] 6 5 0 1 0 0 1
36 Sun 36 3 36 36 36 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 5 ,.- 3 9 0 1 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 . 1 10 0 1 1 0 0
3424 3424 3424 3 34 342 3424 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 0 0 0
May 21, may M Ma May May BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 7 0 , 1 10 0 0 1 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .. 2 5 0 0 0 0 0
the itch the t th the the BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .;:- 4 9 0 1 0 0 1
[PMID: 17653196 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 [::./] 6 6 0 1 0 0 1
37 Sun 37 3 37 37 37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,,. 6 9 0 1 0 0 1
basis of basis b ba bas basi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .;:-[: 6 8 0 1 0 0 1
19661382 DOI: 19661382 1 19 196 1966 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 0 :./.] 5 5 0 1 0 0 1
38 Lagerström 38 3 38 38 38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 9 0 1 0 0 1
Nordenankar K, nordenankar N No Nor Nord BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 8 0 1 0 0 1
JN, Wallén-Mackenzie jn, J JN JN, JN, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,-,.- 5 7 0 1 0 0 1
sensory neurons sensory s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 1 0 0 1
Neuron 2010; neuron N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ;:-[::./ 8 8 0 1 0 0 1
j.neuron.2010.09.016] j.neuron.2010.09.016] j.neuron.2010.09.016] j j. j.n j.ne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ....] 5 3 0 1 0 0 1
39 Liu 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,,, 6 9 0 1 0 0 1
RR, Lowell rr, R RR RR, RR, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,.- 4 8 0 1 0 0 1
from nociceptors from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 1 0 0 1
Neuron 2010; neuron N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ;:-[::./ 8 8 0 1 0 0 1
j.neuron.2010.09.008] j.neuron.2010.09.008] j.neuron.2010.09.008] j j. j.n j.ne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ....] 5 3 0 1 0 0 1
40 Tokumura 40 4 40 40 40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,, 4 7 0 1 0 0 1
K, Yasuda k, K K, K, K, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,. 3 8 0 1 0 0 1
lysophospholipase D, lysophospholipase l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,-, 3 9 0 1 0 0 1
as autotaxin, as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
2002; 277: 2002; 2 20 200 2002 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ;:-[::./. 9 8 0 1 0 0 1
M205623200] M205623200] m205623200] M M2 M20 M205 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ] 1 1 0 1 0 0 1
41 Umezu-Goto 41 4 41 41 41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 -,,,,, 6 8 0 1 0 0 1
K, Yamori k, K K, K, K, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,,. 6 9 0 1 0 0 1
lysophospholipase D lysophospholipase l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 9 0 1 0 0 1
motility by motility m mo mot moti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .; 2 9 0 1 0 0 1
158: 227-233 158: 1 15 158 158: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 :-[::./.] 9 8 0 1 0 0 1
42 Kremer 42 4 42 42 42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 8 0 1 0 0 1
Mettang T, mettang M Me Met Mett BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 9 0 1 0 0 1
Davies NA, davies D Da Dav Davi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ,,,,,. 6 9 0 1 0 0 1
Serum autotaxin serum S Se Ser Seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 10 0 1 0 0 1
other origin, other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 10 0 1 0 0 1
2012; 56: 2012; 2 20 201 2012 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ;:-[::./.] 10 8 0 1 0 0 1
43 Kremer 43 4 43 43 43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 8 0 1 0 0 1
Tolenaars D, tolenaars T To Tol Tole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,-,,,, 6 9 0 1 0 0 1
Williamson C, williamson W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ,,. 3 9 0 1 0 0 1
a high a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 0 . 1 9 0 1 0 0 1
J Hepatol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 ;:-[::./ 8 8 0 1 0 0 1
j.jhep.2014.10.041] j.jhep.2014.10.041] j.jhep.2014.10.041] j j. j.j j.jh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ....] 5 2 0 1 0 0 1
44 Green 44 4 44 44 44 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 .. 2 9 0 1 0 0 1
1977; 18: 1977; 1 19 197 1977 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ;:-[:] 6 4 0 1 0 0 1
45 Alemi 45 4 45 45 45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,,, 6 10 0 1 0 0 1
F, Steinhoff f, F F, F, F, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,-,- 7 9 0 1 0 0 1
Morales E, morales M Mo Mor Mora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ,,,,, 5 8 0 1 0 0 1
Bunnett NW, bunnett B Bu Bun Bunn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,.- 3 8 0 1 0 0 1
induced itch induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .;:- 4 9 0 1 0 0 1
[PMID: 23524965 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 [::./] 6 5 0 1 0 0 1
46 Lieu 46 4 46 46 46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,,, 6 8 0 1 0 0 1
McIntyre P, mcintyre M Mc McI McIn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 ,,,,, 5 8 0 1 0 0 1
Korbmacher C, korbmacher K Ko Kor Korb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 9 0 1 0 0 1
Corvera CU, corvera C Co Cor Corv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
the TRPA1 the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 1 0 0 1
2014; 147: 2014; 2 20 201 2014 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ;:-[::./ 8 7 0 1 0 0 1
j.gastro.2014.08.042] j.gastro.2014.08.042] j.gastro.2014.08.042] j j. j.g j.ga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ....] 5 3 0 1 0 0 1
47 Cousins 47 4 47 47 47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
of opioids. of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .;:-[:] 7 8 0 1 0 0 1
48 Ballantyne 48 4 48 48 48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,. 3 9 0 1 0 0 1
spinal opiates. spinal s sp spi spin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .;:-[:] 7 8 0 1 0 0 1
49 Bernstein 49 4 49 49 49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,. 4 9 0 1 0 0 1
effect of effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
Dermatol 1982; dermatol D De Der Derm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ;:-[:] 6 6 0 1 0 0 1
50 Bergasa 50 5 50 50 50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,,,, 5 8 0 1 0 0 1
Baker BL, baker B Ba Bak Bake BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 ,,,,. 5 8 0 1 0 0 1
controlled trial controlled c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 0 1 0 0 1
cholestasis. Gastroenterology cholestasis. c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .;:-[: 6 8 0 1 0 0 1
1732125] 1732125] 1732125] 1 17 173 1732 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ] 1 1 0 1 0 0 1
51 Thornton 51 5 51 51 51 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,,. 3 8 0 1 0 0 1
impaired hepatic impaired i im imp impa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 0 1 0 0 1
peptides? Gut peptides? p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ?;:-[:] 7 7 0 1 0 0 1
52 Thornton 52 5 52 52 52 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 ,. 2 9 0 1 0 0 1
and renal and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .;:-[:] 7 8 0 1 0 0 1
53 Thornton 53 5 53 53 53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
in plasma in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 . 1 9 0 1 0 0 1
Hepatol 1989; hepatol H He Hep Hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ;:-[:] 6 5 0 1 0 0 1
54 Togashi 54 5 54 54 54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,, 5 7 0 1 0 0 1
Honda T, honda H Ho Hon Hond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 6 ,,,,, 5 8 0 1 0 0 1
T, Nagase t, T T, T, T, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.- 3 9 0 1 0 0 1
agonist, TRK-820. agonist, a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,-.;:-[: 8 8 0 1 0 0 1
11821035] 11821035] 11821035] 1 11 118 1182 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 ] 1 1 0 1 0 0 1
55 Umeuchi 55 5 55 55 55 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,, 5 8 0 1 0 0 1
T, Nagase t, T T, T, T, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,.- 3 8 0 1 0 0 1
scratching behavior scratching s sc scr scra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 , 1 8 0 1 0 0 1
activation of activation a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -.;: 4 8 0 1 0 0 1
29-35 [PMID: 29-35 2 29 29- 29-3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -[:] 4 3 0 1 0 0 1
56 Inan 56 5 56 56 56 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,.,, 4 9 0 1 0 0 1
inhibits scratching inhibits i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
chronic ethynylestradiol chronic c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 9 0 1 0 0 1
Behav 2006; behav B Be Beh Beha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ;:-[::./ 8 7 0 1 0 0 1
j.pbb.2006.07.004] j.pbb.2006.07.004] j.pbb.2006.07.004] j j. j.p j.pb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 ....] 5 2 0 1 0 0 1
57 Dimoulios 57 5 57 57 57 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,, 5 8 0 1 0 0 1
Koulentaki M, koulentaki K Ko Kou Koul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,,. 4 8 0 1 0 0 1
Ursodeoxycholic acid ursodeoxycholic U Ur Urs Urso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
in primary in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 .;: 3 9 0 1 0 0 1
227-234 [PMID: 227-234 2 22 227 227- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -[::./.-... 11 8 0 1 0 0 1
x] x] x] x x] x] x] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ] 1 0 0 1 0 0 1
58 Andoh 58 5 58 58 58 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,.- 3 9 0 1 0 0 1
itch-associated responses itch-associated i it itc itch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -.;: 4 8 0 1 0 0 1
202-208 [PMID: 202-208 2 20 202 202- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -[::./..] 9 7 0 1 0 0 1
59 Tajiri 59 5 59 59 59 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,. 5 8 0 1 0 0 1
hypotension and hypotension h hy hyp hypo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 9 0 1 0 0 1
ascites: role ascites: a as asc asci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 :.;:- 5 8 0 1 0 0 1
[PMID: 7590659] [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 [:] 3 2 0 1 0 0 1
60 Bigliardi 60 6 60 60 60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,-,,. 5 9 0 1 0 0 1
mu-opiate receptor mu-opiate m mu mu- mu-o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 -. 2 9 0 1 0 0 1
Dermatol 1998; dermatol D De Der Derm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ;:-[::./ 8 8 0 1 0 0 1
j.1523-1747.1998.00259.x] j.1523-1747.1998.00259.x] j.1523-1747.1998.00259.x] j j. j.1 j.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 .-...] 6 3 0 1 0 0 1
61 Tominaga 61 6 61 61 61 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,. 3 9 0 1 0 0 1
opioid systems opioid o op opi opio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 . 1 9 0 1 0 0 1
2007; 127: 2007; 2 20 200 2007 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 ;:-[::./ 8 7 0 1 0 0 1
sj.jid.5700942] sj.jid.5700942] sj.jid.5700942] s sj sj. sj.j BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 ..] 3 2 0 1 0 0 1
62 Rishe 62 6 62 62 62 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,.: 4 10 0 1 0 0 1
patients' perspective. patients' p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 '.;:-[: 7 9 0 1 0 0 1
18176748 DOI: 18176748 1 18 181 1817 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 6 :./-] 5 5 0 1 0 0 1
63 Mells 63 6 63 63 63 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,, 5 8 0 1 0 0 1
Heneghan MA, heneghan H He Hen Hene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,, 5 8 0 1 0 0 1
Alexander GJ, alexander A Al Ale Alex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
perceived quality perceived p pe per perc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 :-. 3 9 0 1 0 0 1
2013; 58: 2013; 2 20 201 2013 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 ;:-[::./.] 10 8 0 1 0 0 1
64 Zein 64 6 64 64 64 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
biliary cirrhosis biliary b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 . 1 8 0 1 0 0 1
Gastroenterol Rep gastroenterol G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ;:-[:: 6 7 0 1 0 0 1
10.1007/s11894-009-0079-2] 10.1007/s11894-009-0079-2] 10.1007/s11894-009-0079-2] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 ./---] 6 3 0 1 0 0 1
65 Pusl 65 6 65 65 65 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
bile duct bile b bi bil bile BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .;:- 4 9 0 1 0 0 1
[PMID: 16773706 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 [::./...] 9 6 0 1 0 0 1
66 Talwalkar 66 6 66 66 66 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,. 4 9 0 1 0 0 1
of pruritus of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 9 0 1 0 0 1
2003; 1: 2003; 2 20 200 2003 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 ;:-[:] 6 4 0 1 0 0 1
67 Heathcote 67 6 67 67 67 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 .. 2 8 0 1 0 0 1
American Association american A Am Ame Amer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 8 0 1 0 0 1
guidelines. Hepatology guidelines. g gu gui guid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .;:-[: 6 8 0 1 0 0 1
DOI: 10.1053/he.2000.5984] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 :./..] 6 3 0 1 0 0 1
68 Neuberger 68 6 68 68 68 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
pruritus is pruritus p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 9 0 1 0 0 1
antagonist therapy. antagonist a an ant anta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .;: 3 8 0 1 0 0 1
1393-1394 [PMID: 1393-1394 1 13 139 1393 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 6 -[:] 4 3 0 1 0 0 1
69 Bonacini 69 6 69 69 69 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 . 1 7 0 1 0 0 1
immunodeficiency virus, immunodeficiency i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,. 2 9 0 1 0 0 1
Liver Dis liver L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 ;:-[:] 6 6 0 1 0 0 1
70 Dega 70 7 70 70 70 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 ,,,,,, 6 8 0 1 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 . 1 10 0 1 1 0 0
3425 3425 3425 3 34 342 3425 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 0 0 0 0
May 21, may M Ma May May BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 9 0 , 1 10 0 0 1 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 5 0 0 0 0 0
Laporte JL, laporte L La Lap Lapo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 0 ,,,,.[ 6 9 0 1 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .]. 3 8 0 1 0 0 1
Venereol 1998; venereol V Ve Ven Vene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ;:-[:] 6 5 0 1 0 0 1
71 Cacoub 71 7 71 71 71 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,,,, 5 9 0 1 0 0 1
JC, Opolon jc, J JC JC, JC, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,.. 3 9 0 1 0 0 1
MULTIVIRC Group. multivirc M MU MUL MULT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 8 0 1 0 0 1
1999; 42: 1999; 1 19 199 1999 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ;:-[::./-( 10 8 0 1 0 0 1
199910)42] 199910)42] 199910)42] 1 19 199 1999 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 )] 2 1 0 1 0 0 1
72 Geenes 72 7 72 72 72 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,.. 3 9 0 1 0 0 1
World J world W Wo Wor Worl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ;:-[: 5 8 0 1 0 0 1
DOI: 10.3748/wjg.15.2049] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 :./..] 6 3 0 1 0 0 1
73 Pathak 73 7 73 73 73 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,.. 4 9 0 1 0 0 1
Gynecol Clin gynecol G Gy Gyn Gyne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ;:-[:: 6 8 0 1 0 0 1
10.1016/j.ogc.2010.02.011] 10.1016/j.ogc.2010.02.011] 10.1016/j.ogc.2010.02.011] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ./....] 7 3 0 1 0 0 1
74 Glantz 74 7 74 74 74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,. 3 9 0 1 0 0 1
of pregnancy: of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 : 1 9 0 1 0 0 1
complication rates. complication c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .;:-[: 6 8 0 1 0 0 1
15368452 DOI: 15368452 1 15 153 1536 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 0 :./.] 5 4 0 1 0 0 1
75 van 75 7 75 75 75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,. 3 8 0 1 0 0 1
future therapies future f fu fut futu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
Gastroenterol 2017; gastroenterol G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ;:-[::./ 8 8 0 1 0 0 1
wjg.v23.i5.763] wjg.v23.i5.763] wjg.v23.i5.763] w wj wjg wjg. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ...] 4 2 0 1 0 0 1
76 Summerskill 76 7 76 76 76 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,. 2 8 0 1 0 0 1
"obstructive" jaundice. "obstructive" " "o "ob "obs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 "".;:-[: 8 7 0 1 0 0 1
13835689] 13835689] 13835689] 1 13 138 1383 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ] 1 1 0 1 0 0 1
77 Mcphedran 77 7 77 77 77 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,.. 3 8 0 1 0 0 1
Assoc J assoc A As Ass Asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ;:-[:] 6 6 0 1 0 0 1
78 Lindor 78 7 78 78 78 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,,,, 5 8 0 1 0 0 1
Heathcote EJ. heathcote H He Hea Heat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ..;: 4 8 0 1 0 0 1
291-308 [PMID: 291-308 2 29 291 291- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 -[::./.] 8 6 0 1 0 0 1
79 European 79 7 79 79 79 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
Practice Guidelines: practice P Pr Pra Prac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 :. 2 9 0 1 0 0 1
J Hepatol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 ;:-[::./ 8 8 0 1 0 0 1
j.jhep.2009.04.009] j.jhep.2009.04.009] j.jhep.2009.04.009] j j. j.j j.jh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ....] 5 2 0 1 0 0 1
80 Parés 80 8 80 80 80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,.- 4 9 0 1 0 0 1
patients with patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
to ursodeoxycholic to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .;:- 4 8 0 1 0 0 1
[PMID: 16530513 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 [::./....] 10 7 0 1 0 0 1
81 Kuiper 81 8 81 81 81 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,,-, 5 8 0 1 0 0 1
van Ditzhuijsen van v va van van BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 ,,,, 4 8 0 1 0 0 1
van Erpecum van v va van van BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 ,. 2 8 0 1 0 0 1
with primary with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
to ursodeoxycholic to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .;:- 4 9 0 1 0 0 1
[PMID: 19208346 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 [::./....] 10 7 0 1 0 0 1
82 Lindor 82 8 82 82 82 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 9 0 1 0 0 1
Primary Sclerosing primary P Pr Pri Prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 1 0 0 1
Group. N group. G Gr Gro Grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 .;:-[:: 7 8 0 1 0 0 1
10.1056/NEJM199703063361003] 10.1056/NEJM199703063361003] 10.1056/nejm199703063361003] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ./] 3 4 0 1 0 0 1
83 Chappell 83 8 83 83 83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,,,, 5 8 0 1 0 0 1
Thornton JG. thornton T Th Tho Thor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 0 ., 2 9 0 1 0 0 1
delivery versus delivery d de del deli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 0 1 0 0 1
cholestasis of cholestasis c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :. 2 9 0 1 0 0 1
BMJ 2012; bmj B BM BMJ BMJ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ;:[::./. 8 7 0 1 0 0 1
e3799] e3799] e3799] e e3 e37 e379 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ] 1 1 0 1 0 0 1
84 Duncan 84 8 84 84 84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,. 3 9 0 1 0 0 1
chronic obstructive chronic c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .(); 4 9 0 1 0 0 1
289: 22 289: 2 28 289 289: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 :[:] 4 3 0 1 0 0 1
85 Di 85 8 85 85 85 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,,.- 5 9 0 1 0 0 1
placebo-controlled clinical placebo-controlled p pl pla plac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 1 0 0 1
the treatment the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 --: 3 9 0 1 0 0 1
between itching between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 1 0 0 1
Pharmacol 1984; pharmacol P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ;:-[:] 6 6 0 1 0 0 1
86 Mela 86 8 86 86 86 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,.: 4 9 0 1 0 0 1
cholestatic and cholestatic c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .; 2 9 0 1 0 0 1
17: 857-870 17: 1 17 17: 17: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 :-[:] 5 4 0 1 0 0 1
87 Khurana 87 8 87 87 87 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,. 2 10 0 1 0 0 1
to chronic to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 :-- 3 9 0 1 0 0 1
controlled trials. controlled c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .;:-[: 6 9 0 1 0 0 1
DOI: 10.1111/j.1478-3231.2006.01326.x] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 :./.-...] 9 5 0 1 0 0 1
88 Bachs 88 8 88 88 88 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,,,,.- 6 9 0 1 0 0 1
term rifampicin term t te ter term BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 . 1 8 0 1 0 0 1
Gastroenterology 1992; gastroenterology G Ga Gas Gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ;:-[:] 6 7 0 1 0 0 1
89 Martínez 89 8 89 89 89 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,. 3 9 0 1 0 0 1
rifampin. Pathogenetic rifampin. r ri rif rifa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .,, 3 8 0 1 0 0 1
management strategies, management m ma man mana BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 5 ,- 2 8 0 1 0 0 1
reactions. Medicine reactions. r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .();:-[: 8 8 0 1 0 0 1
10575418] 10575418] 10575418] 1 10 105 1057 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ] 1 1 0 1 0 0 1
90 Imam 90 9 90 90 90 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,. 4 9 0 1 0 0 1
management of management m ma man mana BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 5 . 1 9 0 1 0 0 1
Hepatol 2012; hepatol H He Hep Hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ;:-[::./ 8 8 0 1 0 0 1
j.1440-1746.2012.07109.x] j.1440-1746.2012.07109.x] j.1440-1746.2012.07109.x] j j. j.1 j.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 .-...] 6 3 0 1 0 0 1
91 Bergasa 91 9 91 91 91 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 8 0 1 0 0 1
Turner ML, turner T Tu Tur Turn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 5 ,,,. 4 9 0 1 0 0 1
infusions in infusions i in inf infu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .- 2 9 0 1 0 0 1
blind, randomized, blind, b bl bli blin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,.;: 5 9 0 1 0 0 1
161-167 [PMID: 161-167 1 16 161 161- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -[:] 4 3 0 1 0 0 1
92 Wolfhagen 92 9 92 92 92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 9 0 1 0 0 1
Buuren HR. buuren B Bu Buu Buur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .: 2 9 0 1 0 0 1
double-blind, placebo-controlled double-blind, d do dou doub BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -,-.; 5 9 0 1 0 0 1
113: 1264-1269 113: 1 11 113 113: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 :-[:] 5 4 0 1 0 0 1
93 Terg 93 9 93 93 93 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,. 5 9 0 1 0 0 1
safety of safety s sa saf safe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 , 1 9 0 1 0 0 1
crossover, double crossover, c cr cro cros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,-.; 5 9 0 1 0 0 1
37: 717-722 37: 3 37 37: 37: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 :-[:] 5 4 0 1 0 0 1
94 Mansour-Ghanaei 94 9 94 94 94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 -,,,,- 6 8 0 1 0 0 1
Toosi M, toosi T To Too Toos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,, 4 7 0 1 0 0 1
Ebrahimi-Dariani N, ebrahimi-dariani E Eb Ebr Ebra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -,,. 4 8 0 1 0 0 1
naltrexone on naltrexone n na nal nalt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 10 0 1 0 0 1
2006; 12: 2006; 2 20 200 2006 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ;:-[::./.. 10 8 0 1 0 0 1
i7.1125] i7.1125] i7.1125] i i7 i7. i7.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 .] 2 1 0 1 0 0 1
95 Phan 95 9 95 95 95 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,. 4 8 0 1 0 0 1
treatment with treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -:. 3 9 0 1 0 0 1
J Am j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 5 ;:-[:: 6 8 0 1 0 0 1
10.1016/j.jaad.2009.08.052] 10.1016/j.jaad.2009.08.052] 10.1016/j.jaad.2009.08.052] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ./....] 7 4 0 1 0 0 1
96 Ando 96 9 96 96 96 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 8 0 1 0 0 1
Miyamoto Y. miyamoto M Mi Miy Miya BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 8 0 1 0 0 1
involved in involved i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -, 2 9 0 1 0 0 1
nalfurafine hydrochloride. nalfurafine n na nal nalf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .;: 3 8 0 1 0 0 1
257-264 [PMID: 257-264 2 25 257 257- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -[::./.] 8 6 0 1 0 0 1
97 Nakao 97 9 97 97 97 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 9 0 1 0 0 1
S, Tanaka s, S S, S, S, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,,,. 4 8 0 1 0 0 1
pharmacological characterization pharmacological p ph pha phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
nalfurafine hydrochloride. nalfurafine n na nal nalf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .;:- 4 8 0 1 0 0 1
[PMID: 22981641 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 [::./....] 10 7 0 1 0 0 1
98 Kumada 98 9 98 98 98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 8 0 1 0 0 1
K, Nakamoto k, K K, K, K, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,. 2 9 0 1 0 0 1
with chronic with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 :, 2 9 0 1 0 0 1
double-blind trial. double-blind d do dou doub BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -.;[: 5 9 0 1 0 0 1
27753159 DOI: 27753159 2 27 277 2775 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 5 :./.] 5 4 0 1 0 0 1
99 Mayo 99 9 99 99 99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 8 0 1 0 0 1
AJ. Sertraline aj. A AJ AJ. AJ. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .-. 3 9 0 1 0 0 1
Hepatology 2007; hepatology H He Hep Hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ;:-[::./ 8 8 0 1 0 0 1
hep.21553] hep.21553] hep.21553] h he hep hep. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 .] 2 1 0 1 0 0 1
100 Alallam 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,. 3 9 0 1 0 0 1
the treatment the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 9 0 1 0 0 1
biliary cirrhosis: biliary b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 :.;: 4 9 0 1 0 0 1
505-507 [PMID: 505-507 5 50 505 505- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -[:] 4 3 0 1 0 0 1
101 Fuhrmann 101 1 10 101 101 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,. 3 9 0 1 0 0 1
support systems support s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
pruritus. Liver pruritus. p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .;:-[:: 7 9 0 1 0 0 1
10.1111/j.1478-3231.2011.02584.x] 10.1111/j.1478-3231.2011.02584.x] 10.1111/j.1478-3231.2011.02584.x] 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ./.-...] 8 4 0 1 0 0 1
102 Parés 102 1 10 102 102 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 9 0 1 0 0 1
A, Rodés a, A A, A, A, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.: 3 8 0 1 0 0 1
prolonged relief prolonged p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 9 0 1 0 0 1
biliary cirrhosis. biliary b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .;:-[: 6 9 0 1 0 0 1
15180733 DOI: 15180733 1 15 151 1518 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 5 :./.-...] 9 6 0 1 0 0 1
103 Leckie 103 1 10 103 103 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 ,,,,, 5 8 0 1 0 0 1
R. 'Out-patient' r. R R. R. R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .'-' 4 9 0 1 0 0 1
intractable pruritus. intractable i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .;:- 4 9 0 1 0 0 1
[PMID: 22260552 [pmid: [ [P [PM [PMI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 [::./.-...] 11 7 0 1 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 . 1 10 0 1 1 0 0
3426 3426 3426 3 34 342 3426 BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 0 0 0 0 0
May 21, may M Ma May May BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 1 0 0 11 0 , 1 10 0 0 1 0 0
WJG|www.wjgnet.com WJG|www.wjgnet.com wjg|www.wjgnet.com W WJ WJG WJG| BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .. 2 5 0 0 0 0 0
104 Parés 104 1 10 104 104 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,,,,. 5 8 1 1 0 0 1
resistant pruritus resistant r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 : 1 9 1 1 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .;: 3 8 1 1 0 0 1
307-312 [PMID: 307-312 3 30 307 307- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -[::./....] 11 8 1 1 0 0 1
105 Pusl 105 1 10 105 105 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,,,. 4 9 1 1 0 0 1
anion adsorption anion a an ani anio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 no 0 9 1 1 0 0 1
biliary cirrhosis. biliary b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .;:-[: 6 9 1 1 0 0 1
DOI: 10.1016/j.jhep.2006.08.008] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 :./....] 8 4 1 1 0 0 1
106 Decock 106 1 10 106 106 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,,,, 4 9 1 1 0 0 1
D, Verslype d, D D, D, D, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,,.- 6 9 1 1 0 0 1
pruritus treated pruritus p pr pru prur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 : 1 9 1 1 0 0 1
case series case c ca cas case BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 .;:-[: 6 9 1 1 0 0 1
DOI: 10.1016/j.jhep.2012.04.023] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 :./....] 8 4 1 1 0 0 1
107 Beuers 107 1 10 107 107 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,,. 3 10 1 1 0 0 1
intractable pruritus intractable i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .; 2 9 1 1 0 0 1
44: 280-281 44: 4 44 44: 44: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 :-[::./.] 9 7 1 1 0 0 1
108 Kumagai 108 1 10 108 108 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,,,,, 5 8 1 1 0 0 1
Suzuki H. suzuki S Su Suz Suzu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 .-, 3 9 1 1 0 0 1
hydrochloride, on hydrochloride, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,: 2 9 1 1 0 0 1
Phase III, phase P Ph Pha Phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,,-,-. 6 9 1 1 0 0 1
Nephrol Dial nephrol N Ne Nep Neph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ;:-[: 5 8 1 1 0 0 1
DOI: 10.1093/ndt/gfp588] doi: D DO DOI DOI: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 :.//] 5 3 1 1 0 0 1
109 Kumagai 109 1 10 109 109 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 ,,,,, 5 8 1 1 0 0 1
Nakamoto H, nakamoto N Na Nak Naka BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,. 4 8 1 1 0 0 1
safety of safety s sa saf safe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 8 1 1 0 0 1
in dialysis in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 5 .;:-[: 6 8 1 1 0 0 1
22868684 DOI: 22868684 2 22 228 2286 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 5 :./] 4 4 1 1 0 0 1
110 Pellicciari 110 1 11 110 110 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 ,,,,, 5 10 1 1 0 0 1
Maloney PR, maloney M Ma Mal Malo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 5 ,,,.-- 6 8 1 1 0 0 1
chenodeoxycholic acid chenodeoxycholic c ch che chen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 (-), 4 8 1 1 0 0 1
agonist endowed agonist a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .; 2 9 1 1 0 0 1
45: 3569-3572 45: 4 45 45: 45: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 :-[:] 5 4 1 1 0 0 1
111 Lindor 111 1 11 111 111 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 . 1 9 1 1 0 0 1
cirrhosis. Curr cirrhosis. c ci cir cirr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .;:-[: 6 8 1 1 0 0 1
21297469 DOI: 21297469 2 21 212 2129 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 5 :./.] 5 6 1 1 0 0 1
112 Nevens 112 1 11 112 112 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 ,,,,, 5 8 1 1 0 0 1
Invernizzi P, invernizzi I In Inv Inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,,,,, 5 9 1 1 0 0 1
M, Jones m, M M, M, M, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,,,,,, 6 9 1 1 0 0 1
van Erpecum van v va van van BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 5 ,,,,, 5 8 1 1 0 0 1
Hansen B, hansen H Ha Han Hans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 5 ,,,,- 5 8 1 1 0 0 1
Rad R, rad R Ra Rad Rad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 5 ,,,,, 5 8 1 1 0 0 1
M, Shapiro m, M M, M, M, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.- 3 9 1 1 0 0 1
Primary Biliary primary P Pr Pri Prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 .;:- 4 8 1 1 0 0 1
[PMID: 27532829 [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 [::./] 6 6 1 1 0 0 1
113 Bolier 113 1 11 113 113 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 ,,,. 4 10 1 1 0 0 1
cholestatic pruritus. cholestatic c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .;:- 4 9 1 1 0 0 1
[PMID: 23402082] [pmid: [ [P [PM [PMI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 [:] 3 2 1 1 0 0 1
114 Jones 114 1 11 114 114 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 ,.. 3 9 1 1 0 0 1
1999; 29: 1999; 1 19 199 1999 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 ;:-[::./ 8 7 1 1 0 0 1
hep.510290450] hep.510290450] hep.510290450] h he hep hep. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 .] 2 2 1 1 0 0 1
P-Reviewer: Chamuleau p-reviewer: P P- P-R P-Re BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 -:,-: 5 10 1 0 0 0 1
L-Editor: A l-editor: L L- L-E L-Ed BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 -:-: 4 5 1 0 0 0 1
Tajiri K tajiri T Ta Taj Taji BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 . 1 10 0 1 1 0 0
© 2017 © © © © © BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 0 .. 2 10 1 0 0 0 0
Published by published P Pu Pub Publ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 no 0 7 1 0 0 0 1
7901 Stoneridge 7901 7 79 790 7901 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 1 ,,,, 4 10 1 0 0 0 1
Telephone: +1-925-223-8242 telephone: T Te Tel Tele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 :--- 4 4 1 0 0 0 1
Fax: +1-925-223-8243 fax: F Fa Fax Fax: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 :--- 4 3 1 0 0 0 1
E-mail: bpgoffice@wjgnet.com e-mail: E E- E-m E-ma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 1 -:. 3 4 1 0 0 0 1
Help Desk: help H He Hel Help BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 :://../ 7 8 1 0 0 0 1
http://www.wjgnet.com http://www.wjgnet.com http://www.wjgnet.com h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 1 11 1 ://.. 5 3 1 0 0 0 1
I S i I I I I BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 8 - 1 10 1 0 0 0 1
9 7 9 9 9 9 9 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 9 no 0 10 1 0 0 0 0
1 9 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 11 no 0 10 1 0 0 0 0

